Gain Therapeutics, Inc. (GANX) Financials

$1.69

$0.05 (-2.87%)
Last update: 06/17/25, 11:41:11 AM EST
Day's range
$1.66
Day's range
$1.8
$5M$5M$0$0-$5M-$5M-$10M-$10M-$15M-$15M-$20M-$20M-$25M-$25MEarning2018201820192019202020202021202120222022202320232024202410000%10000%0%0%-10000%-10000%-20000%-20000%-30000%-30000%-40000%-40000%-50000%-50000%Profit Margin
Profit Margin
Revenue
Earnings

GANX Income statement / Annual

Last year (2024), Gain Therapeutics, Inc.'s total revenue was $0.00, a decrease of 100.00% from the previous year. In 2024, Gain Therapeutics, Inc.'s net income was -$20.41 M. See Gain Therapeutics, Inc.,s key income statements, including revenue, expenses, profit, and income.

Period FY-2024 FY-2023 FY-2022 FY-2021 FY-2020 FY-2019 FY-2018
Period Ended 12/31/2024 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018
Operating Revenue $0.00 $55.18 K $140.11 K $164.99 K $28.88 K $41.30 K $20.61 K
Cost of Revenue $84.07 K $80.38 K $64.17 K $7.16 M $2.26 M $0.00 $0.00
Gross Profit $0.00 -$25.20 K $75.94 K -$7.00 M -$2.23 M $41.30 K $20.61 K
Gross Profit Ratio 0 -0.46 0.54 -42.42 -77.22 1 1
Research and Development Expenses $10.79 M $11.52 M $8.38 M $7.16 M $2.26 M $1.59 M $826.88 K
General & Administrative Expenses $9.56 M $10.79 M $9.54 M $6.83 M $1.25 M $555.17 K $222.05 K
Selling & Marketing Expenses $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Selling, General & Administrative Expenses $9.56 M $10.79 M $9.54 M $6.83 M $1.25 M $555.17 K $222.05 K
Other Expenses $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Operating Expenses $20.35 M $22.31 M $17.92 M $13.99 M $3.51 M $2.14 M $1.05 M
Cost And Expenses -$20.35 M $22.31 M $17.92 M $13.99 M $3.51 M $2.14 M $1.05 M
Interest Income $0.00 $494.23 K $375.36 K $12.50 K $3.64 K $20.54 K $0.00
Interest Expense $0.00 $0.00 $0.00 $0.00 $0.00 $20.54 K $0.00
Depreciation & Amortization $84.07 K $83.58 K $64.17 K $15.48 K $9.59 K $2.57 K $741.00
EBITDA -$19.79 M -$22.17 M -$17.78 M -$13.82 M -$3.47 M -$2.10 M -$1.03 M
EBITDA Ratio 0 -401.77 -126.88 -83.77 -120.14 -50.79 -49.86
Operating Income Ratio 0 -403.28 -126.88 -83.8 -120.48 -50.85 -49.9
Total Other Income/Expenses Net $476.22 K $64.89 K $279.28 K -$60.43 K -$92.85 K -$86.22 K -$67.44 K
Income Before Tax -$19.87 M -$22.19 M -$17.50 M -$13.89 M -$3.57 M -$2.19 M -$1.10 M
Income Before Tax Ratio 0 -402.11 -124.89 -84.16 -123.69 -52.94 -53.17
Income Tax Expense $536.82 K $79.28 K $92.98 K $4.01 K $5.39 K $7.11 K $9.78 K
Net Income -$20.41 M -$22.27 M -$17.59 M -$13.89 M -$3.58 M -$2.19 M -$1.11 M
Net Income Ratio 0 -403.54 -125.55 -84.19 -123.88 -53.11 -53.64
EPS -0.89 -1.71 -1.48 -1.37 -0.3 -0.18 -0.19
EPS Diluted -0.89 -1.71 -1.48 -1.37 -0.3 -0.18 -0.19
Weighted Average Shares Out $22.88 M $13.01 M $11.88 M $10.17 M $11.88 M $11.88 M $5.86 M
Weighted Average Shares Out Diluted $22.88 M $13.01 M $11.88 M $10.17 M $11.88 M $11.88 M $5.86 M
Link